ProSciento was founded 17 years ago with a mission to advance clinical research and development for metabolic diseases through focused scientific and operational expertise. We have conducted more than 305 clinical projects, supporting the advancement of today’s medically relevant metabolic drug classes. We are now recognized as the leading provider of clinical research services for NASH, diabetes, and obesity drug and device development. At the heart of these accomplishments is our team of scientific and medical professionals, who have decades of hands-on experience and a track record of success designing and conducting clinical programs for metabolic diseases.
Our Unparalleled Experience in Metabolic Clinical Research:
Diabetes, NASH and obesity clinical projects completed
Contributions to 17 approved metabolic drugs and devices